Literature DB >> 8380070

Avian retroviral RNA encapsidation: reexamination of functional 5' RNA sequences and the role of nucleocapsid Cys-His motifs.

R Aronoff1, A M Hajjar, M L Linial.   

Abstract

RNA packaging signals (psi) from the 5' ends of murine and avian retroviral genomes have previously been shown to direct encapsidation of heterologous mRNA into the retroviral virion. The avian 5' packaging region has now been further characterized, and we have defined a 270-nucleotide sequence, A psi, which is sufficient to direct packaging of heterologous RNA. Identification of the A psi sequence suggests that several retroviral cis-acting sequences contained in psi+ (the primer binding site, the putative dimer linkage sequence, and the splice donor site) are dispensable for specific RNA encapsidation. Subgenomic env mRNA is not efficiently encapsidated into particles, even though the A psi sequence is present in this RNA. In contrast, spliced heterologous psi-containing RNA is packaged into virions as efficiently as unspliced species; thus splicing per se is not responsible for the failure of env mRNA to be encapsidated. We also found that an avian retroviral mutant deleted for both nucleocapsid Cys-His boxes retains the capacity to encapsidate RNA containing psi sequences, although this RNA is unstable and is thus difficult to detect in mature particles. Electron microscopy reveals that virions produced by this mutant lack a condensed core, which may allow the RNA to be accessible to nucleases.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8380070      PMCID: PMC237350     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

1.  Recombinant avian oncoviruses. II. Alterations in the gag proteins and evidence for intragenic recombination.

Authors:  R Shaikh; M Linial; S Brown; A Sen; R Eisenman
Journal:  Virology       Date:  1979-01-30       Impact factor: 3.616

2.  Creation of a processed pseudogene by retroviral infection.

Authors:  M Linial
Journal:  Cell       Date:  1987-04-10       Impact factor: 41.582

3.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

4.  Evidence that the packaging signal of Moloney murine leukemia virus extends into the gag region.

Authors:  M A Bender; T D Palmer; R E Gelinas; A D Miller
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

5.  Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus.

Authors:  R Mann; R C Mulligan; D Baltimore
Journal:  Cell       Date:  1983-05       Impact factor: 41.582

6.  An avian oncovirus mutant (SE 21Q1b) deficient in genomic RNA: biological and biochemical characterization.

Authors:  M Linial; E Medeiros; W S Hayward
Journal:  Cell       Date:  1978-12       Impact factor: 41.582

7.  A deletion mutation in the 5' part of the pol gene of Moloney murine leukemia virus blocks proteolytic processing of the gag and pol polyproteins.

Authors:  S Crawford; S P Goff
Journal:  J Virol       Date:  1985-03       Impact factor: 5.103

8.  Continuous tissue culture cell lines derived from chemically induced tumors of Japanese quail.

Authors:  C Moscovici; M G Moscovici; H Jimenez; M M Lai; M J Hayman; P K Vogt
Journal:  Cell       Date:  1977-05       Impact factor: 41.582

9.  Murine leukemia virus maturation: protease region required for conversion from "immature" to "mature" core form and for virus infectivity.

Authors:  I Katoh; Y Yoshinaka; A Rein; M Shibuya; T Odaka; S Oroszlan
Journal:  Virology       Date:  1985-09       Impact factor: 3.616

10.  Transcription of three c-myc exons is enhanced in chicken bursal lymphoma cell lines.

Authors:  M Linial; M Groudine
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

View more
  56 in total

1.  An Mpsi-containing heterologous RNA, but not env mRNA, is efficiently packaged into avian retroviral particles.

Authors:  J D Banks; B O Kealoha; M L Linial
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

2.  A LINE-like transposable element in Drosophila, the I factor, encodes a protein with properties similar to those of retroviral nucleocapsids.

Authors:  A Dawson; E Hartswood; T Paterson; D J Finnegan
Journal:  EMBO J       Date:  1997-07-16       Impact factor: 11.598

3.  RNA dimerization defect in a Rous sarcoma virus matrix mutant.

Authors:  L J Parent; T M Cairns; J A Albert; C B Wilson; J W Wills; R C Craven
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

4.  Multiple biological roles associated with the Rous sarcoma virus 5' untranslated RNA U5-IR stem and loop.

Authors:  J T Miller; Z Ge; S Morris; K Das; J Leis
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

5.  NC-mediated nucleolar localization of retroviral gag proteins.

Authors:  Timothy L Lochmann; Darrin V Bann; Eileen P Ryan; Andrea R Beyer; Annie Mao; Alan Cochrane; Leslie J Parent
Journal:  Virus Res       Date:  2012-10-02       Impact factor: 3.303

6.  An integration-defective U5 deletion mutant of human immunodeficiency virus type 1 reverts by eliminating additional long terminal repeat sequences.

Authors:  E Vicenzi; D S Dimitrov; A Engelman; T S Migone; D F Purcell; J Leonard; G Englund; M A Martin
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

7.  Solution structure of the Rous sarcoma virus nucleocapsid protein: muPsi RNA packaging signal complex.

Authors:  Jing Zhou; Rebecca L Bean; Volker M Vogt; Michael Summers
Journal:  J Mol Biol       Date:  2006-10-10       Impact factor: 5.469

8.  Mutational analysis of cis-acting packaging signals in human immunodeficiency virus type 1 RNA.

Authors:  J Luban; S P Goff
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

9.  Transforming variants of the avian myc-containing retrovirus FH3 arise prior to phenotypic selection.

Authors:  A T Tikhonenko; M L Linial
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

10.  Requirement of the Pr55gag precursor for incorporation of the Vpr product into human immunodeficiency virus type 1 viral particles.

Authors:  C Lavallée; X J Yao; A Ladha; H Göttlinger; W A Haseltine; E A Cohen
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.